We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Amgen, Genentech Await Del. Ruling In Biosimilar IP Row

Law360, Los Angeles (January 11, 2018, 6:13 PM EST) -- A California federal judge on Thursday tentatively paused Amgen’s suit seeking to invalidate more than two dozen patents related to Genentech’s cancer treatment Avastin, saying he wanted to see whether a...
To view the full article, register now.

Related

Sections

Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only

Court

California Central

Nature of Suit

830(Patent)

Judge

Subscribers Only

Date Filed

October 6, 2017

Law Firms

Companies

Government Agencies

Patents

Judge Analytics

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.